Sharon Wei Hung
Clinical Associate Professor, Medicine - Primary Care and Population Health
Bio
Sharon Hung MD, FACP is a board-certified Internal Medicine physician practicing at the Stanford Internal Medicine Clinic in Santa Clara. She earned her MD from the Northwestern University Feinberg School of Medicine and completed her internal medicine residency at Cedars-Sinai Medical Center. Prior to joining Stanford, she served on the faculty at the University of Arizona College of Medicine.
Dr. Hung is the Director of Women’s Health for the Department of Primary Care and Population Health. In this role, she served as course director for Stanford CME’s Women’s Health Conference and continues to co-direct the annual Stanford CME Menopause and Healthy Aging Conference. She also hosts the Stanford CME/YouTube Women’s Health Vodcast, where she interviews leading experts and explores timely, clinically relevant topics in women’s health.
Her scholarly interests include breast cancer screening, steatotic liver disease, osteoporosis, and weight gain during the perimenopausal period. Clinically, she is dedicated to preventive medicine and the management of chronic conditions such as pre-diabetes, obesity and metabolic syndrome, as well as guiding women through the perimenopausal transition. Dr. Hung also leads bi-monthly group patient visits focused on the prevention and treatment of osteoporosis. She is passionate about inspiring trainees and works with both Stanford Internal Medicine residents and Physician Assistant students.
She is conversational in both Spanish and Mandarin.
Clinical Focus
- Internal Medicine
Administrative Appointments
-
Course Director, Women's Health in Primary Care, Stanford CME conference (2023 - Present)
-
Director of Women's Health, Stanford Medicine, Primary Care and Population Health (2023 - Present)
Professional Education
-
MD, Cedars-Sinai Medical Center, Internal Medicine (2014)
-
MD, Northwestern University, Feinberg School of Medicine, Medical School (2011)
-
Board Certification: American Board of Internal Medicine, Internal Medicine (2014)
-
BA, University of California, Berkeley, Public Health (2007)
All Publications
-
Midlife weight gain: challenges and solutions.
Current opinion in obstetrics & gynecology
2026; 38 (2): 94-102
Abstract
Understanding the interplay between aging, hormonal changes, and lifestyle factors is crucial for effective obesity management in midlife and menopausal women. This review is timely given rising rates of obesity and associated comorbidities, the rapid evolution of pharmacologic interventions for obesity, and the growing recognition of the impact of midlife weight gain on women's long-term health.Weight gain in midlife women is primarily driven by age-related metabolic changes, with menopause contributing to unfavorable shifts in body composition and central adiposity. Obesity in menopause is associated with heightened risks of cardiometabolic disease, mood disorders, sleep disturbances, and impaired quality of life. Newer antiobesity medications have substantial efficacy in weight reduction and cardiometabolic risk improvement. Lifestyle interventions - resistance training and Mediterranean diet - remain foundational. Screening for comorbidities and attention to mental health are essential components of care.Management of midlife weight gain in women requires a multifaceted approach, integrating lifestyle modification, pharmacotherapy, and, when appropriate, surgical intervention. Clinicians should prioritize early identification of at-risk individuals, provide anticipatory guidance, and personalize interventions. Ongoing research is needed for evidence-based protocols for weight maintenance after initial loss, along with guidance on maintaining lean muscle mass while on incretin therapy.
View details for DOI 10.1097/GCO.0000000000001093
View details for PubMedID 41740621